| James T May Iv, MD | |
|
161 Wadsworth Dr, North Chesterfield, VA 23236-4500 | |
| (804) 484-3700 | |
| (804) 320-6462 |
| Full Name | James T May Iv |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 19 Years |
| Location | 161 Wadsworth Dr, North Chesterfield, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649479346 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | ME106522 (Florida) | Secondary |
| 207Y00000X | Otolaryngology | E6950 (Arkansas) | Secondary |
| 207Y00000X | Otolaryngology | 0101254177 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bon Secours St Marys Hospital | Richmond, VA | Hospital |
| Cjw Medical Center | Richmond, VA | Hospital |
| Henrico Doctors' Hospital | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Ear Nose And Throat Associates Pc | 6901794999 | 31 |
News Archive
Catalyst Pharmaceutical Partners, Inc. announced today that it has received notice from The NASDAQ Stock Market confirming that the Company has regained compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.
Two-thirds of all human embryos fail to develop successfully. Now, in a new study, researchers at the Stanford University School of Medicine have shown that they can predict with 93 percent certainty which fertilized eggs will make it to a critical developmental milestone and which will stall and die. The findings are important to the understanding of the fundamentals of human development at the earliest stages, which have largely remained a mystery despite the attention given to human embryonic stem cell research.
Children who undergo brain radiation therapy run a significant risk of suffering from permanent neurocognitive adverse effects. These adverse effects are due to the fact that the radiation often encounters healthy tissue. This reduces the formation of new cells, particularly in the hippocampus - the part of the brain involved in memory and learning.
BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices, today announced the launch of a patented, ready-to-use and mouldable version of their osteostimulative BonAlive bioactive glass bone regeneration technology.
Sleep apnea is a very common sleep disorder characterised by breathing pauses and periodic snoring. According to some studies, as much as ten percent of the population suffer from it, but up to nine out of ten cases remain undiagnosed because symptoms are sometimes mild and there are a lack of resources in diagnostics.
› Verified 5 days ago
| Entity Name | Virginia Ear Nose & Throat Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356325757 PECOS PAC ID: 6901794999 Enrollment ID: O20040310000578 |
News Archive
Catalyst Pharmaceutical Partners, Inc. announced today that it has received notice from The NASDAQ Stock Market confirming that the Company has regained compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.
Two-thirds of all human embryos fail to develop successfully. Now, in a new study, researchers at the Stanford University School of Medicine have shown that they can predict with 93 percent certainty which fertilized eggs will make it to a critical developmental milestone and which will stall and die. The findings are important to the understanding of the fundamentals of human development at the earliest stages, which have largely remained a mystery despite the attention given to human embryonic stem cell research.
Children who undergo brain radiation therapy run a significant risk of suffering from permanent neurocognitive adverse effects. These adverse effects are due to the fact that the radiation often encounters healthy tissue. This reduces the formation of new cells, particularly in the hippocampus - the part of the brain involved in memory and learning.
BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices, today announced the launch of a patented, ready-to-use and mouldable version of their osteostimulative BonAlive bioactive glass bone regeneration technology.
Sleep apnea is a very common sleep disorder characterised by breathing pauses and periodic snoring. According to some studies, as much as ten percent of the population suffer from it, but up to nine out of ten cases remain undiagnosed because symptoms are sometimes mild and there are a lack of resources in diagnostics.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James T May Iv, MD 161 Wadsworth Dr, North Chesterfield, VA 23236-4500 Ph: (804) 484-3700 | James T May Iv, MD 161 Wadsworth Dr, North Chesterfield, VA 23236-4500 Ph: (804) 484-3700 |
News Archive
Catalyst Pharmaceutical Partners, Inc. announced today that it has received notice from The NASDAQ Stock Market confirming that the Company has regained compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.
Two-thirds of all human embryos fail to develop successfully. Now, in a new study, researchers at the Stanford University School of Medicine have shown that they can predict with 93 percent certainty which fertilized eggs will make it to a critical developmental milestone and which will stall and die. The findings are important to the understanding of the fundamentals of human development at the earliest stages, which have largely remained a mystery despite the attention given to human embryonic stem cell research.
Children who undergo brain radiation therapy run a significant risk of suffering from permanent neurocognitive adverse effects. These adverse effects are due to the fact that the radiation often encounters healthy tissue. This reduces the formation of new cells, particularly in the hippocampus - the part of the brain involved in memory and learning.
BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices, today announced the launch of a patented, ready-to-use and mouldable version of their osteostimulative BonAlive bioactive glass bone regeneration technology.
Sleep apnea is a very common sleep disorder characterised by breathing pauses and periodic snoring. According to some studies, as much as ten percent of the population suffer from it, but up to nine out of ten cases remain undiagnosed because symptoms are sometimes mild and there are a lack of resources in diagnostics.
› Verified 5 days ago